BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26569607)

  • 1. Loss of Cellular Sialidases Does Not Affect the Sialylation Status of the Prion Protein but Increases the Amounts of Its Proteolytic Fragment C1.
    Katorcha E; Klimova N; Makarava N; Savtchenko R; Pan X; Annunziata I; Takahashi K; Miyagi T; Pshezhetsky AV; d'Azzo A; Baskakov IV
    PLoS One; 2015; 10(11):e0143218. PubMed ID: 26569607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of PrPSc glycoform and prion infectivity.
    Katorcha E; Makarava N; Savtchenko R; D'Azzo A; Baskakov IV
    PLoS Pathog; 2014 Sep; 10(9):e1004366. PubMed ID: 25211026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Nile tilapia Neu1 sialidases: Molecular cloning and biochemical characterization of the sialidases Neu1a and Neu1b.
    Honda A; Chigwechokha PK; Takase R; Hayasaka O; Fujimura K; Kotani T; Komatsu M; Shiozaki K
    Gene; 2020 Jun; 742():144538. PubMed ID: 32184168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NEU1 and NEU3 sialidase activity expressed in human lung microvascular endothelia: NEU1 restrains endothelial cell migration, whereas NEU3 does not.
    Cross AS; Hyun SW; Miranda-Ribera A; Feng C; Liu A; Nguyen C; Zhang L; Luzina IG; Atamas SP; Twaddell WS; Guang W; Lillehoj EP; Puché AC; Huang W; Wang LX; Passaniti A; Goldblum SE
    J Biol Chem; 2012 May; 287(19):15966-80. PubMed ID: 22403397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of endogenous sialidases of human monocytes during cellular differentiation into macrophages.
    Stamatos NM; Liang F; Nan X; Landry K; Cross AS; Wang LX; Pshezhetsky AV
    FEBS J; 2005 May; 272(10):2545-56. PubMed ID: 15885103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning and biochemical characterization of sialidases from zebrafish (Danio rerio).
    Manzoni M; Colombi P; Papini N; Rubaga L; Tiso N; Preti A; Venerando B; Tettamanti G; Bresciani R; Argenton F; Borsani G; Monti E
    Biochem J; 2007 Dec; 408(3):395-406. PubMed ID: 17708749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NEU1 sialidase regulates the sialylation state of CD31 and disrupts CD31-driven capillary-like tube formation in human lung microvascular endothelia.
    Lee C; Liu A; Miranda-Ribera A; Hyun SW; Lillehoj EP; Cross AS; Passaniti A; Grimm PR; Kim BY; Welling PA; Madri JA; DeLisser HM; Goldblum SE
    J Biol Chem; 2014 Mar; 289(13):9121-35. PubMed ID: 24550400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialylation Controls Prion Fate
    Srivastava S; Katorcha E; Daus ML; Lasch P; Beekes M; Baskakov IV
    J Biol Chem; 2017 Feb; 292(6):2359-2368. PubMed ID: 27998976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homology modeling of human sialidase enzymes NEU1, NEU3 and NEU4 based on the crystal structure of NEU2: hints for the design of selective NEU3 inhibitors.
    Magesh S; Suzuki T; Miyagi T; Ishida H; Kiso M
    J Mol Graph Model; 2006 Oct; 25(2):196-207. PubMed ID: 16427342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deregulation of sialidases in human normal and tumor tissues.
    Forcella M; Mozzi A; Stefanini FM; Riva A; Epistolio S; Molinari F; Merlo E; Monti E; Fusi P; Frattini M
    Cancer Biomark; 2018 Feb; 21(3):591-601. PubMed ID: 29278877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymoquinone from nutraceutical black cumin oil activates Neu4 sialidase in live macrophage, dendritic, and normal and type I sialidosis human fibroblast cells via GPCR Galphai proteins and matrix metalloproteinase-9.
    Finlay TM; Jayanth P; Amith SR; Gilmour A; Guzzo C; Gee K; Beyaert R; Szewczuk MR
    Glycoconj J; 2010 Apr; 27(3):329-48. PubMed ID: 20213245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sialylation of the prion protein glycans controls prion replication rate and glycoform ratio.
    Katorcha E; Makarava N; Savtchenko R; Baskakov IV
    Sci Rep; 2015 Nov; 5():16912. PubMed ID: 26576925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LPS-induced cytokine production in human dendritic cells is regulated by sialidase activity.
    Stamatos NM; Carubelli I; van de Vlekkert D; Bonten EJ; Papini N; Feng C; Venerando B; d'Azzo A; Cross AS; Wang LX; Gomatos PJ
    J Leukoc Biol; 2010 Dec; 88(6):1227-39. PubMed ID: 20826611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in lung sialidases in male and female mice after bleomycin aspiration.
    Pilling D; Sahlberg K; Chen W; Gomer RH
    Exp Lung Res; 2022; 48(9-10):291-304. PubMed ID: 36382835
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic Effect of Neuraminidase-1-Selective Inhibition in Mouse Models of Bleomycin-Induced Pulmonary Inflammation and Fibrosis.
    Luzina IG; Lillehoj EP; Lockatell V; Hyun SW; Lugkey KN; Imamura A; Ishida H; Cairo CW; Atamas SP; Goldblum SE
    J Pharmacol Exp Ther; 2021 Jan; 376(1):136-146. PubMed ID: 33139318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acidic sialidase activity is aberrant in obese and diabetic mice.
    Natori Y; Ohkura N; Nasui M; Atsumi G; Kihara-Negishi F
    Biol Pharm Bull; 2013; 36(6):1027-31. PubMed ID: 23727924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper and Zinc Interactions with Cellular Prion Proteins Change Solubility of Full-Length Glycosylated Isoforms and Induce the Occurrence of Heterogeneous Phenotypes.
    Brim S; Groschup MH; Kuczius T
    PLoS One; 2016; 11(4):e0153931. PubMed ID: 27093554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease resistance of infectious prions is suppressed by removal of a single atom in the cellular prion protein.
    Leske H; Hornemann S; Herrmann US; Zhu C; Dametto P; Li B; Laferriere F; Polymenidou M; Pelczar P; Reimann RR; Schwarz P; Rushing EJ; Wüthrich K; Aguzzi A
    PLoS One; 2017; 12(2):e0170503. PubMed ID: 28207746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sialidases on mammalian sperm mediate deciduous sialylation during capacitation.
    Ma F; Wu D; Deng L; Secrest P; Zhao J; Varki N; Lindheim S; Gagneux P
    J Biol Chem; 2012 Nov; 287(45):38073-9. PubMed ID: 22989879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NEU1-selective sialidase inhibitor, C9-butyl-amide-DANA, blocks sialidase activity and NEU1-mediated bioactivities in human lung in vitro and murine lung in vivo.
    Hyun SW; Liu A; Liu Z; Cross AS; Verceles AC; Magesh S; Kommagalla Y; Kona C; Ando H; Luzina IG; Atamas SP; Piepenbrink KH; Sundberg EJ; Guang W; Ishida H; Lillehoj EP; Goldblum SE
    Glycobiology; 2016 Aug; 26(8):834-49. PubMed ID: 27226251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.